Consolidated Balance Sheets - USD ($)
|
Feb. 29, 2020 |
Nov. 30, 2019 |
| Current |
|
|
| Cash |
$ 6,052
|
$ 64,622
|
| Accounts receivable, net |
264,237
|
177,202
|
| Investment tax credits |
775,736
|
775,736
|
| Prepaid expenses, sundry and other assets |
172,312
|
156,616
|
| Inventory (Note 3) |
246,756
|
349,131
|
| Current Assets |
1,465,093
|
1,523,307
|
| Property and equipment, net (Note 4) |
2,138,438
|
2,273,406
|
| Assets |
3,603,531
|
3,796,713
|
| Current |
|
|
| Accounts payable |
3,977,117
|
3,757,018
|
| Accrued liabilities |
1,136,971
|
927,698
|
| Employee costs payable |
1,450,497
|
893,864
|
| Income tax payable (Note 10) |
5,678
|
5,678
|
| Promissory notes payable (Note 5) |
159,863
|
159,863
|
| Convertible debenture (Note 5) |
1,707,131
|
1,744,813
|
| Current Liabilities |
8,437,257
|
7,488,934
|
| Liabilities |
8,437,257
|
7,488,934
|
| Shareholders' equity (deficiency) |
|
|
| Capital stock (Note 6) Authorized: Unlimited common shares without par value, Unlimited preference shares, Issued and outstanding: 23,678,105 common shares (November 30, 2018 - 18,252,243) |
46,144,402
|
45,561,222
|
| Additional paid-in capital |
44,190,409
|
44,167,721
|
| Accumulated other comprehensive income |
284,421
|
284,421
|
| Accumulated deficit |
(95,452,958)
|
(93,705,585)
|
| Shareholders' (Deficiency)/Equity |
(4,833,726)
|
(3,692,221)
|
| Contingencies (Note 11) |
|
|
| Liabilities and Shareholders' (Deficiency)/Equity |
$ 3,603,531
|
$ 3,796,713
|